{"id":933,"date":"2026-05-25T03:50:06","date_gmt":"2026-05-25T03:50:06","guid":{"rendered":"https:\/\/wuhantopmiraclepeptides.com\/?post_type=product&p=933"},"modified":"2026-06-18T17:43:20","modified_gmt":"2026-06-18T17:43:20","slug":"pal-ahk-200mg","status":"publish","type":"product","link":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/product\/pal-ahk-200mg\/","title":{"rendered":"Pal-AHK (200mg)"},"content":{"rendered":"

Pal-AHK (200mg) Research Peptide: A Lipidated Tripeptide for ECM & Fibroblast Studies<\/span><\/h1>\n

If your research investigates extracellular matrix (ECM) dynamics, fibroblast signalling, or the molecular mechanisms underlying hair follicle cycling,\u00a0<\/span>Pal-AHK (200mg) research peptide<\/span><\/strong>\u00a0represents a precisely defined synthetic tool worthy of consideration. Also known as Palmitoyl Tripeptide\u20113, this compound is a lipidated tripeptide (Pal\u2011Ala\u2011His\u2011Lys) that combines the bioactive AHK amino acid sequence with a palmitoyl (C16 fatty acid) chain<\/span>. This structural modification enhances membrane affinity and lipophilicity, making it a potentially useful probe for studying cell\u2011membrane interactions, ECM modulation, and receptor signalling pathways in a range of experimental contexts<\/span>.<\/span><\/p>\n

At\u00a0<\/span>Wuhan Top Miracle Peptides<\/span><\/strong>, we supply high\u2011purity\u00a0<\/span>Pal-AHK (200mg) research peptide<\/span><\/strong>\u00a0to research institutions and wholesale buyers across the\u00a0<\/span>United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA<\/span><\/strong>. Every batch is lyophilised, HPLC\u2011verified to \u226598% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into ECM biology, fibroblast activity, and signalling pathways begin with uncompromising quality.<\/span><\/p>\n

What Is Pal\u2011AHK and How Does It Work?<\/span><\/h2>\n

To fully appreciate the research potential of\u00a0<\/span>Pal-AHK (200mg) research peptide<\/span><\/strong>, it is essential to understand its biochemical design and the mechanistic hypotheses that have emerged from the available literature.<\/span><\/p>\n

The Pal\u2011AHK Tripeptide: Structure and Design<\/span><\/h3>\n

Pal\u2011AHK is a synthetic tripeptide consisting of alanine, histidine, and lysine (AHK), conjugated at the N\u2011terminus with a palmitoyl (hexadecanoyl) group<\/span>. The sequence is\u00a0<\/span>Pal\u2011Ala\u2011His\u2011Lys\u2011OH (Pal\u2011AHK)<\/span><\/strong>. Its molecular formula is\u00a0<\/span>C\u2083\u2081H\u2085\u2086N\u2086O\u2085<\/span><\/strong>, and its molecular weight is approximately\u00a0<\/span>592.81 g\/mol<\/span><\/strong>.<\/span><\/p>\n

The basic residues (histidine and lysine) may confer metal\u2011binding potential, particularly to divalent cations such as copper (Cu\u00b2\u207a), analogous to related peptides like GHK<\/span>. The palmitoyl group\u2014a 16\u2011carbon fatty acid chain\u2014enhances lipophilicity and membrane affinity, supporting interactions within lipid milieus such as cell membranes<\/span>. This dual\u2011phase design may allow Pal\u2011AHK to act as a bridging molecule between membrane components and cytosolic or extracellular targets<\/span>.<\/span><\/p>\n

Proposed Mechanism of Action: ECM Modulation and Signalling<\/span><\/h3>\n

The biological activity of\u00a0<\/span>Pal-AHK (200mg) research peptide<\/span><\/strong>\u00a0is hypothesised to involve multiple intersecting mechanisms:<\/span><\/p>\n

    \n
  • \n

    Fibroblast Signalling:<\/span><\/strong>\u00a0Pal\u2011AHK functions as a signalling molecule that interacts with dermal fibroblasts and endothelial cells<\/span>. It stimulates the production of\u00a0<\/span>type I collagen, fibronectin, and glycosaminoglycans<\/span><\/strong>\u2014key extracellular matrix components essential for tissue architecture<\/span>.<\/span><\/p>\n<\/li>\n

  • \n

    ECM Synthesis and Remodelling:<\/span><\/strong>\u00a0In cell culture experiments, the non\u2011lipidated AHK has been associated with elevated collagen type I production\u2014some reports quantify up to a\u00a0<\/span>~300% increase<\/span><\/strong>\u00a0in collagen I synthesis under peptide exposure<\/span>. The lipidated derivative may improve penetration into ECM\u2011adjacent areas<\/span>.<\/span><\/p>\n<\/li>\n

  • \n

    MMP Modulation:<\/span><\/strong>\u00a0Pal\u2011AHK appears to suppress excessive matrix metalloproteinase (MMP) activity in contexts where ECM degradation is pathologically elevated, such as in fibrotic models or engineered tissue remodelling assays<\/span>.<\/span><\/p>\n<\/li>\n

  • \n

    Angiogenic Signalling:<\/span><\/strong>\u00a0Computational docking studies propose that AHK residues may interact with VEGFR2 (vascular endothelial growth factor receptor 2), implying a possible modulatory role in angiogenic signalling<\/span>. The peptide also upregulates VEGF, enhancing blood supply to support cellular regeneration<\/span>.<\/span><\/p>\n<\/li>\n

  • \n

    Cellular Survival and Apoptosis:<\/span><\/strong>\u00a0AHK has been reported to shift the\u00a0<\/span>Bcl\u20112\/Bax ratio<\/span><\/strong>\u00a0toward cell survival and reduce markers of apoptosis, such as cleaved caspase\u20113 and PARP cleavage<\/span>.<\/span><\/p>\n<\/li>\n

  • \n

    Antioxidant Action:<\/span><\/strong>\u00a0Pal\u2011AHK may exhibit anti\u2011oxidative activity, helping to neutralise free radicals that cause oxidative stress and cellular damage<\/span>.<\/span><\/p>\n<\/li>\n<\/ul>\n

    Research Note: Palmitoylation and Activity<\/span><\/h3>\n

    Studies have primarily investigated the action of non\u2011palmitoylated AHK<\/span>. However, Pal\u2011AHK likely exerts similar impacts, as adding a palmitoyl group is not expected to significantly alter the compound’s mechanism of action<\/span>. Palmitoylation is typically considered to enhance cell penetration capacity, which may make the peptide more capable of exerting its effects in experimental settings<\/span>.<\/span><\/p>\n

    Key Research Applications for Pal\u2011AHK (200mg)<\/span><\/h2>\n

    Pal-AHK (200mg) research peptide<\/span><\/strong>\u00a0is a versatile tool with potential applications spanning several domains of biomedical research.<\/span><\/p>\n

    1. Extracellular Matrix (ECM) and Fibroblast Research<\/span><\/h3>\n

    The most established research area for Pal\u2011AHK lies in its interface with ECM regulation<\/span>. Applications include:<\/span><\/p>\n